{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:55:15Z","timestamp":1788990915849,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL131517"],"award-info":[{"award-number":["R01-HL131517"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-TR001860"],"award-info":[{"award-number":["UL1-TR001860"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1-TR001861"],"award-info":[{"award-number":["TL1-TR001861"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15SDG24910015"],"award-info":[{"award-number":["15SDG24910015"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005859","name":"Heart Rhythm Society","doi-asserted-by":"publisher","award":["16OA9HRS"],"award-info":[{"award-number":["16OA9HRS"]}],"id":[{"id":"10.13039\/100005859","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00799","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T04:29:57Z","timestamp":1510028997000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"],"prefix":"10.3389","volume":"8","author":[{"given":"Nicholas","family":"Ellinwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Morotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.bpj.2017.03.022","article-title":"Rate-dependent role of IKur in human atrial repolarization and atrial fibrillation maintenance","volume":"112","author":"Aguilar","year":"2017","journal-title":"Biophys. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1113\/jphysiol.1996.sp021194","article-title":"Differences between outward currents of human atrial, and subepicardial ventricular myocytes","volume":"491","author":"Amos","year":"1996","journal-title":"J. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ","volume":"114","author":"Andrade","year":"2014","journal-title":"Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tcm.2012.04.004","article-title":"Human atrial fibrillation: insights from computational electrophysiological models. Trends Cardiovasc","volume":"21","author":"Bers","year":"2011","journal-title":"Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0008-6363(99)00178-9","article-title":"Ionic mechanisms of electrical remodeling in human atrial fibrillation","volume":"44","author":"Bosch","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"B6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0022-3565(25)12140-X","article-title":"Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5","volume":"275","author":"Bouchard","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1006\/jmcc.2000.1221","article-title":"The ultrarapid and the transient outward K+ current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation","volume":"32","author":"Brandt","year":"2000","journal-title":"J. Mol. Cell Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.jacc.2010.02.028","article-title":"In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both","volume":"55","author":"Caballero","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1517\/14740338.2014.915311","article-title":"Comprehensive in vitro proarrhythmia assay, a novel in vitro\/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative","volume":"13","author":"Cavero","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/bjp.2008.209","article-title":"Pathology-specific effects of the IKur\/Ito\/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation","volume":"154","author":"Christ","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/eurheartj\/ehs442","article-title":"Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation","volume":"34","author":"Christophersen","year":"2013","journal-title":"Eur. Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1005587","DOI":"10.1371\/journal.pcbi.1005587","article-title":"In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis","volume":"13","author":"Colman","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1003543","DOI":"10.1371\/journal.pcbi.1003543","article-title":"Comprehensive analyses of ventricular myocyte models identify targets exhibiting favorable rate dependence","volume":"10","author":"Cummins","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.15252\/emmm.201404757","article-title":"Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology","volume":"7","author":"Devalla","year":"2015","journal-title":"EMBO Mol. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.yjmcc.2015.07.016","article-title":"There and back again: iterating between population-based modeling and experiments reveals surprising regulation of calcium transients in rat cardiac myocytes","volume":"96","author":"Devenyi","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00395-003-0409-8","article-title":"Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res","volume":"98","author":"Dobrev","year":"2003","journal-title":"Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jacc.2007.08.067","article-title":"Atrial-selective approaches for the treatment of atrial fibrillation","volume":"51","author":"Ehrlich","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"093918","DOI":"10.1063\/1.5000226","article-title":"Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity","volume":"27","author":"Ellinwood","year":"2017","journal-title":"Chaos"},{"key":"B19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/FJC.0b013e3181719b0c","article-title":"New drugs targeting the cardiac ultra-rapid delayed-rectifier current IKur: rationale, pharmacology and evidence for potential therapeutic value","volume":"52","author":"Ford","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.hrthm.2015.10.003","article-title":"The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation","volume":"13","author":"Ford","year":"2016","journal-title":"Heart Rhythm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/FJC.0b013e31828780eb","article-title":"Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5\/IKur inhibitor","volume":"61","author":"Ford","year":"2013","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"B23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1540-8167.2000.tb00024.x","article-title":"Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation","volume":"11","author":"Grammer","year":"2000","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2016.09.012","article-title":"Anti-arrhythmic strategies for atrial fibrillation: the role of computational modeling in discovery, development, and optimization. Pharmacol","volume":"168","author":"Grandi","year":"2016","journal-title":"Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/CIRCRESAHA.111.253955","article-title":"Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation. Circ","volume":"109","author":"Grandi","year":"2011","journal-title":"Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4022\/jafib.495","article-title":"Altered excitation-contraction coupling in human chronic atrial fibrillation","volume":"4","author":"Grandi","year":"2012","journal-title":"J. Atr. Fibrillation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ","volume":"114","author":"Heijman","year":"2014","journal-title":"Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1124\/jpet.106.101162","article-title":"Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current","volume":"317","author":"Lagrutta","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/cpt.367","article-title":"Improved prediction of drug-induced torsades de pointes through simulations of dynamics and machine learning algorithms","volume":"100","author":"Lancaster","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pbiomolbio.2015.12.005","article-title":"In silico assessment of kinetics and state dependent binding properties of drugs causing acquired LQTS","volume":"120","author":"Lee","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.bpj.2012.12.055","article-title":"Parameter sensitivity analysis of stochastic models provides insights into cardiac calcium sparks. Biophys","volume":"104","author":"Lee","year":"2013","journal-title":"J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e004628","DOI":"10.1161\/CIRCEP.116.004628","article-title":"Improving the In silico assessment of proarrhythmia risk by combining hERG (human ether-a-go-go-related gene) channel-drug binding kinetics and multichannel pharmacology","volume":"10","author":"Li","year":"2017","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fphar.2014.00026","article-title":"Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation","volume":"5","author":"Loose","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.drudis.2017.01.015","article-title":"Bringing new dimensions to drug discovery screening: impact of cellular stimulation technologies","volume":"22","author":"Molokanova","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mex.2016.12.002","article-title":"Logistic regression analysis of populations of electrophysiological models to assess proarrythmic risk","volume":"4","author":"Morotti","year":"2017","journal-title":"MethodsX"},{"key":"B36","doi-asserted-by":"publisher","first-page":"274a","DOI":"10.1016\/j.bpj.2015.11.1487","article-title":"Small-conductance Ca2+-activated K+ current in atrial fibrillation: both friend and foe","volume":"110","author":"Morotti","year":"","journal-title":"Biophys. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.07.030","article-title":"Atrial-selective targeting of arrhythmogenic phase-3 early afterdepolarizations in human myocytes","volume":"96","author":"Morotti","year":"","journal-title":"J. Mol. Cell Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/19336950.2017.1293220","article-title":"Predominant contribution of L-type Cav1.2 channel stimulation to impaired intracellular calcium and cerebral artery vasoconstriction in diabetic hyperglycemia","volume":"11","author":"Morotti","year":"2017","journal-title":"Channels"},{"key":"B39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrcardio.2016.118","article-title":"Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation","volume":"13","author":"Nattel","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/2211068215623209","article-title":"Automated patch clamp meets high-throughput screening: 384 cells recorded in parallel on a planar patch clamp module","volume":"21","author":"Obergrussberger","year":"2016","journal-title":"J. Lab. Autom."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/hmg\/ddl143","article-title":"Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation","volume":"15","author":"Olson","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/bs.apcsb.2016.01.002","article-title":"Contribution of automated technologies to ion channel drug discovery","volume":"104","author":"Picones","year":"2016","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1113\/jphysiol.2013.256115","article-title":"Atrial selectivity of antiarrhythmic drugs","volume":"591","author":"Ravens","year":"2013","journal-title":"J. Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"H1146","DOI":"10.1152\/ajpheart.00668.2011","article-title":"The Na+\/K+ pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue","volume":"302","author":"Sanchez","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cardiores.2006.11.024","article-title":"Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+\/Ca2+-exchange","volume":"73","author":"Schotten","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0735-1097(99)00488-X","article-title":"Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide","volume":"35","author":"Shinagawa","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bpj.2008.10.056","article-title":"Parameter sensitivity analysis in electrophysiological models using multivariable regression. Biophys","volume":"96","author":"Sobie","year":"2009","journal-title":"J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"H793","DOI":"10.1152\/ajpheart.01229.2007","article-title":"In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling","volume":"294","author":"Tsujimae","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1006\/jmcc.2000.1147","article-title":"Molecular basis of electrical remodeling in atrial fibrillation","volume":"32","author":"Van Wagoner","year":"2000","journal-title":"J. Mol. Cell Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.hrthm.2014.11.011","article-title":"Progress toward the prevention and treatment of atrial fibrillation: a summary of the heart rhythm society research forum on the treatment and prevention of atrial fibrillation, Washington, DC, December 9\u201310, 2013","volume":"12","author":"Van Wagoner","year":"2015","journal-title":"Heart Rhythm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/01.RES.80.6.772","article-title":"Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation","volume":"80","author":"Van Wagoner","year":"1997","journal-title":"Circ. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/01.RES.78.4.697","article-title":"Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells. Circ","volume":"78","author":"Wang","year":"1996","journal-title":"Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/01.CIR.0000145155.60288.71","article-title":"Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation","volume":"110","author":"Wettwer","year":"2004","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0008-6363(01)00380-7","article-title":"The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation","volume":"52","author":"Workman","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.81.4.512","article-title":"Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation","volume":"81","author":"Yue","year":"1997","journal-title":"Circ. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0300-8932(09)71687-2","article-title":"Changes in atrial effective refractory period and IKACh after vagal stimulation plus rapid pacing in the pulmonary vein","volume":"62","author":"Zhao","year":"2009","journal-title":"Rev. Esp. Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e42295","DOI":"10.1371\/journal.pone.0042295","article-title":"Markov models of use-dependence and reverse use-dependence during the mouse cardiac action potential","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T22:08:40Z","timestamp":1750975720000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":57,"alternative-id":["10.3389\/fphar.2017.00799"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00799","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,7]]},"article-number":"799"}}